PI
IPXL

Putnam Investments’s Impax Laboratories, Inc. IPXL Stock Holding History

Putnam Investments’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-15,161
Closed -$191K – 1396
2017
Q1 		$191K Sell
15,161
-24,175
-61% -$292K ﹤0.01% 1228
2016
Q4 		$521K Sell
39,336
-1,985
-5% -$33.9K ﹤0.01% 1117
2016
Q3 		$979K Sell
41,321
-737,835
-95% -$19.8M ﹤0.01% 1025
2016
Q2 		$22.5M Buy
779,156
+92,779
+14% +$3.02M 0.05% 275
2016
Q1 		$22M Buy
686,377
+430,645
+168% +$15.1M 0.05% 278
2015
Q4 		$10.9M Sell
255,732
-1,523
-0.6% -$60.8K 0.02% 437
2015
Q3 		$9.06M Sell
257,255
-10,748
-4% -$484K 0.02% 469
2015
Q2 		$12.3M Sell
268,003
-196,859
-42% -$9.34M 0.02% 423
2015
Q1 		$21.8M Sell
464,862
-152,423
-25% -$6.06M 0.04% 327
2014
Q4 		$19.6M Sell
617,285
-223,155
-27% -$6.53M 0.04% 345
2014
Q3 		$19.9M Buy
840,440
+359,952
+75% +$9.22M 0.04% 329
2014
Q2 		$14.4M Sell
480,488
-7,007
-1% -$189K 0.03% 392
2014
Q1 		$12.9M Buy
487,495
+392,746
+415% +$9.82M 0.03% 415
2013
Q4 		$2.38M Buy
+94,749
New +$2.11M 0.01% 1001

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Putnam Investments's IPXL Position: Q2 2017 in Review

Putnam Investments sold out of Impax Laboratories, Inc. (IPXL) in Q2 2017, closing a stake of 15,161 shares — an estimated $191K sold.

Putnam Investments first reported a position in IPXL in Q4 2013 and held it in 14 quarters. The position peaked at $22.5M in Q2 2016. 172 funds tracked by Wall St. Rank hold IPXL as of Q2 2017.

  • Putnam Investments reported no remaining Impax Laboratories, Inc. position as of Q2 2017 after selling out during the quarter.
  • Putnam Investments sold 15,161 Impax Laboratories, Inc. shares in Q2 2017, an estimated $191K.
  • Putnam Investments first reported a position in Impax Laboratories, Inc. in Q4 2013 and held it in 14 quarters.
  • Putnam Investments's Impax Laboratories, Inc. position peaked at $22.5M in Q2 2016.
  • 172 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2017.

Based on Putnam Investments's 13F filing for Q2 2017, filed 14 Aug 2017.